ADVANCEMENTS IN HEART FAILURE TREATMENT: CURRENT STRATEGIES AND FUTURE  DIRECTIONS OF PHARMACOTHERAPY

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/10267

Full metadata record

DC Field	Value	Language
dc.contributor.author	Pulatova N. I., Yakubov A.V	-
dc.date.accessioned	2024-01-16T05:35:57Z	-
dc.date.available	2024-01-16T05:35:57Z	-
dc.date.issued	2023	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/10267	-
dc.description.abstract	The importance and necessity of further research into this pathological syndrome are determined by the high incidence of chronic heart failure (CHF) in the population (1-2%), an increase in the average age of newly diagnosed patients, a progressive course, the need for inpatient treatment, and an unfavorable prognosis. This article discusses new, effective directions for the pharmacological and non-drug correction of cardiac dysfunction in the treatment of CHF patients, numerous evolutionary changes in the heart failure problem, strategies for enhancing quality of life, and life expectancy for CHF patients.	en_US
dc.language.iso	en_US	en_US
dc.publisher	Ўзбекистон, Тошкент	en_US
dc.relation.ispartofseries	УДК;616-08-039.73.-616.12-008	-
dc.subject	chronic heart failure, pharmacotherapy, pathogenetic treatment	en_US
dc.title	ADVANCEMENTS IN HEART FAILURE TREATMENT: CURRENT STRATEGIES AND FUTURE DIRECTIONS OF PHARMACOTHERAPY	en_US
dc.type	Article	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
4.pdf	ADVANCEMENTS IN HEART FAILURE TREATMENT: CURRENT STRATEGIES AND FUTURE DIRECTIONS OF PHARMACOTHERAPY	16.14 MB	Adobe PDF	View/Open

DSpace JSPUI